Gene: CENPV
Official Full Name: centromere protein Vprovided by HGNC
Gene Summary: Predicted to enable carbon-sulfur lyase activity and metal ion binding activity. Involved in several processes, including centromere complex assembly; pericentric heterochromatin formation; and positive regulation of cytokinesis. Acts upstream of or within ameboidal-type cell migration. Located in several cellular components, including midbody; nucleus; and spindle midzone. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37613 | CENPV Knockout cell line (HeLa) | Human | CENPV | 1:3~1:6 | Negative | Online Inquiry |
KO37614 | CENPV Knockout cell line (HCT 116) | Human | CENPV | 1:2~1:4 | Negative | Online Inquiry |
KO37615 | CENPV Knockout cell line (HEK293) | Human | CENPV | 1:3~1:6 | Negative | Online Inquiry |
KO37616 | CENPV Knockout cell line (A549) | Human | CENPV | 1:3~1:4 | Negative | Online Inquiry |
CENPV Gene Knockout Cell Lines are specifically engineered cellular models that have had the CENPV gene inactivated through precise genome editing techniques, such as CRISPR-Cas9. This gene is a critical component of the centrosome function and plays a pivotal role in cell division and stability. By knocking out the CENPV gene, these cell lines provide researchers with valuable tools to explore the consequences of its absence in various physiological and pathological contexts.
The primary function of CENPV gene knockout is to elucidate the role of the CENPV protein in microtubule dynamics and spindle assembly during mitosis. This inactivation allows for the assessment of phenotypic changes, including alterations in cell cycle progression, chromosomal stability, and apoptosis. Mechanistically, studies involving these knockout models can lead to insights into oncogenic processes, as aberrations in centrosome function are frequently linked to tumorigenesis.
Scientifically, CENPV Gene Knockout Cell Lines are invaluable in both research and clinical settings. They serve as robust models for drug discovery, particularly in the development of anti-cancer therapeutics targeting centrosome-related mechanisms. Their application extends to the study of developmental biology, genetics, and regenerative medicine, making them versatile tools in various fields of biomedical research.
Compared to alternative cell lines, our CENPV knockout models offer the advantage of specificity and reproducibility, ensuring that results are both reliable and interpretable. The precise nature of the gene editing process minimizes off-target effects, a common issue faced in traditional knockout methodologies. Additionally, our cell lines are validated through extensive characterization, ensuring their consistency and viability for long-term experiments.
In summary, CENPV Gene Knockout Cell Lines represent a crucial advancement for researchers and clinicians aiming to understand the complex biology of cell division. By providing precise tools for genetic analysis, our product supports the ongoing quest for innovative therapeutic strategies. Our company's expertise in tissue engineering and genetic modification positions us as leaders in the development of biological products that empower the scientific community to advance their research objectives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.